Cancer cells need a higher amount of energy to allow survival in restrictive conditions (e.g., low pH and oxygen concentrations). 1 However, they show a predominant glycolytic flux if compared with differentiated cells which, conversely, rely upon oxidative phosphorylation (OXPHOS) for most of their energy.
have been developed and their anticancer property has been investigated. Among them, there are: (i) gossypol, a drug that blocks glycolysis by inhibiting NAD + -dependent enzymes, 5 and (ii) 2-deoxy-D-glucose (2-DG), a glucose analogue phosphorylated by hexokinase, but not further metabolized by phosphoglucose isomerase. 6 Although an increased glycolytic rate is required for proliferation, 7 this strategy has only moderate effects in those cancer cells, like HeLa cells, which generate ATP mainly through OXPHOS. 8 In this case, a more successful strategy is based on the simultaneous blockage of glycolysis and OXPHOS pathways by a combined use of inhibitors, e.g., Rhodamine 123, an OXPHOS uncoupler, together with 2-DG; 9 or by using a specific inhibitor
Histograms depicted in Figure 1A show that in the first 6 h of treatment extracellular lactate was significantly reduced, a phenomenon that was dependent on the concentration of either kaempferol or glucose in culture media. Indeed, cells cultured in low-glucose (5.6 mM) were much more affected by kaempferol treatment than those cultured in normal, high-glucose (25 mM), D-MEM. Therefore, to evaluate directly the efficiency of glucose uptake, we performed experiments in the presence of 100 µM 2-NBDG, a fluorescent non-metabolizable analogue of glucose. Figure 1A shows that HeLa cells treated with 200 µM kaempferol for 30 min were less fluorescent than untreated cells. Moreover, cytofluorometric evaluations pointed out that kaempferol-treated cells showed a 61 ± 4% decrease of 2-NBDG uptake with respect to untreated cells (Fig. 1A) .
Changes in the glycolytic pathway could affect the mitochondrial OXPHOS; therefore, we performed analyses of oxygen consumption on HeLa cell suspension. Six hour-treatment with 200 µM kaempferol did not produce significant changes in respiration rate (data not shown). Conversely, 12 h-treatment showed a significant decrease of total oxygen consumption (4.51 ± 0.43 vs. 7.35 ± 0.25 nmol O atom x min -1 x mg prot -1 , n = 5, p < 0.01). To determine which complex of the mitochondrial transfer chain was mainly affected, we analyzed oxygen consumption by each Complex upon permeabilization of the cells with digitonin after 12 h of treatment. Figure 1B shows that kaempferol specifically affected NADH-dependent mitochondrial respiration at Complex I, whereas no significant inhibition was obtained for the other mitochondrial components. We then moved on to purified mitochondria from mouse liver and used them to assess whether kaempferol could directly influence electron transfer chain. Oxygen consumption was determined upon the addition of 50 µM kaempferol in the buffer assay containing purified mitochondria. Succinate-dependent respiration was not significantly affected by kaempferol (data not shown), whereas oxygen consumption was inhibited when NADH was added in experimental buffer containing glutamate/malate. Figure 1C shows that total oxygen consumption significantly decreased (6.72 ± 1.83 versus 12.10 ± 3.12 nmol O atom x min -1 x mg prot -1 , n = 5, p < 0.01), indicating that kaempferol is able to hinder mitochondrial respiration at the level of Complex I.
On the basis of these results, we wondered whether total ATP content could be affected by kaempferol; therefore cells were treated with 200 µM kaempferol up to 24 h, and ATP evaluated. A significant reduction of ATP content was determined after 12 h-treatment in low-glucose conditions, while no significant change were observed when the cells were grown in normal medium (high-glucose) (Fig. 1D) .
Metabolic stress induced by kaempferol activates autophagy. The energetic failures induced by kaempferol can be associated with the activation of autophagy as a survival mechanism. This protective response results in resistance to the toxic effects of drugs that elicits cell death by creating metabolic stress. 29 We then investigated the possibility that HeLa cells underwent autophagy as adaptive response to kaempferol-mediated energetic stress. Figure 2A shows optic microscopy images of a typical morphology of HeLa cells after 12 h-treatment with 200 µM of both glycolysis and OXPHOS, such as 3-bromopyruvate. 10, 11 However, it is well known that during tumor invasion, cancer cells show high tolerance to nutrient deprivation because of their excessive demand for nutrition and oxygen without neovascularization. In particular, it has been demonstrated that nutrient starvation in vitro is a key factor for tumor progression, 12 and that AMP-activated protein kinase (AMPK) plays a major role in protecting tumor cells from metabolic stresses. 13 AMPK is an evolutionary conserved heterotrimeric kinase regulated by alterations in cellular energetic status. Increase of AMP/ATP ratio leads to conformational changes of AMPK that renders the protein accessible for the phosphorylation on Thr 172 by the upstream kinases, such as LKB1 and Calcium/ calmodulin-dependent protein kinase kinase (CaMKK).
14 Once phosphorylated, AMPK is active and stimulates the pathways converging in the generation of ATP by phosphorylation of specific substrates (enzymes and transcription factors). Among the substrates phosphorylated by AMPK, there are several enzymes involved in glycolysis, fatty acid metabolism and mitochondrial biogenesis.
14 Moreover, a role for AMPK in the activation of the mitogen activated protein kinases (MAPK), or in the inhibition of mammalian target of rapamycin (mTOR) pathway has also emerged. 15 Therefore, a more general implication of AMPK in regulating cell fate by influencing autophagy and apoptosis should be considered.
Flavonoids are a huge class of polyphenols largely distributed in plants. Flavonoids mostly derive from benzo-γ-pyrone and can be divided into 14 sub-classes that differ for substituting groups of ring A, B and C. 16 Among the members of the sub-class of flavonols, the most common compounds are quercetin, myricetin and kaempferol. Many studies demonstrated that flavonoids have high antioxidant properties, 17, 18 which explain why their consumption is often associated with a reduced risk of cancer and cardiovascular diseases. 19, 20 Moreover, at pharmacological concentrations, flavonoids are also able to act as pro-oxidants and to induce apoptosis, thus behaving as promising therapeutic agents to be used as co-adjuvant in cancer treatment. [21] [22] [23] The general mechanism of action of polyphenols involves the activation of pro-apoptotic members of MAPK, but a comprehensive analysis of their cellular effects has not been reported yet. In this study, we describe the capability of kaempferol to affect glucose uptake prior to inhibition of the mitochondrial electron transfer chain, and how the resulting energetic stress is buffered by the activation of autophagy via the AMPK/mTOR-mediated pathway.
Results
Kaempferol affects glucose uptake and inhibits mitochondrial respiration. Kaempferol is a flavonol recently proposed to exert antiproliferative effects on tumors. 24 Since the inhibition of glucose uptake has been proposed to occur upon treatment with various polyphenols, 25, 26 we wondered whether this event was also involved in kaempferol treatment. We treated HeLa cells with 100 and 200 µM kaempferol, concentrations similar to those employed in other studies regarding the toxic effects of kaempferol, 27, 28 and measured lactate levels in culture media.
represent autolysosomes, 30 with the cells grown in low-glucose being more autophagic than those cultured under high-glucose. Colocalization analyses of LC3 and lysosomes stained with the lysosome-specific probe LysoTracker Red ® shows that LC3 co-localized with lysosomes, especially at 12 h of treatment (Fig. 2C) . We then attempted to measure cytofluorometrically the extent of autophagic cells taking advantage of acridine orange staining. 11, 31 kaempferol. The same phenotype was evidenced even at low concentrations, with the number of shrinking cells decreasing in a dose-dependent manner (data not shown). HeLa cells were then transfected with a vector expressing the EGFP-conjugated microtubule-associated protein 1 light chain 3 (LC3), treated for 12 h with kaempferol and monitored for the presence of dotted fluorescence. Figure 2B shows discrete green spots, which reasonably kaempferol. This phenomenon, which was reverted by siRNA against Atg5, was also associated with a considerable increase of LC3-II immuno-reactive band and with its redistribution in discrete spots (likely auto-phagolysosomes) (Suppl. Fig. 2A-E) .
To verify that autophagy played a protective role under our experimental conditions, we performed pulse-chase experiments consisting in treating HeLa cells with 200 µM kaempferol for different times, after which the medium was replaced and the cells cultured up to 48 h in fresh medium. Figure 4A shows that kaempferol removal after 12 h-treatment rescued cells from apoptosis. Conversely, when the replacement of the medium was carried out after 24 h, an increase of apoptotic cells at 48 h to values close to 40% was reached. These results confirmed that 24 h was the time where cell survival seems to be completely compromised and autophagy no more able to repress the apoptotic machinery. Next, HeLa cells treated for 6 and 12 h with kaempferol, were rinsed with fresh medium, reseeded in kaempferol-free milieu and cell growth monitored for further 48 h by direct counts upon Trypan blue exclusion. Figure 4B shows that the amount of apoptotic cells did not increase after reseeding. Moreover, viable cells after kaempferol removal still remain viable and were able to replicate, confirming that autophagy was a protective event upon kaempferol-mediated insult (Fig. 4C) .
Prolonged incubations with kaempferol result in ROSdependent and MAPK-mediated apoptosis. We analyzed whether chronic incubation with kaempferol resulted in apoptosis by cytofluorometric analyses of HeLa cells, upon staining with propidium iodide. Histograms depicted in Figure 5A show cell cycle distribution of cells treated for 48 h with different concentrations of kaempferol. Under these conditions, a dose-dependent (between 50 and 200 µM) increase in the percentage of subG 1 (apoptotic) cells was evidenced. We characterized the apoptotic pathway by evaluating the levels of pro-and active caspase-9, caspase-8, as well as caspase-3 and poly-ADP ribose polymerase (PARP) by western blot analyses. Results reported in Figure 5B show that each step of the intrinsic apoptotic program (caspase 9-mediated) was executed, whereas no activation of the receptordependent apoptosis (caspase 8-mediated) seemed to occur under our experimental conditions. Conversely, western blots performed after 24 h-treatment indicated that this was the time sufficient to induce only the cleavage of caspase-9, but not the proteolysis of Figure 2D shows that the percentage of cells emitting in bright red fluorescence (autophagic) increased in a time-dependent manner, and to a different extent depending on growth conditions. We also performed western blot analyses of LC3 in HeLa cells treated with increasing doses of kaempferol. Figure 2E shows that resting HeLa cells shows a marked expression of the immune-reactive band representative of LC3-II if compared with other cells lines (e.g., neuroblastoma cells SH-SY5Y), however treatments with kaempferol induced a dose and time-dependent increase of LC3 II, with HeLa cells grown in low-glucose being the most responsive.
HeLa cells activate autophagy as survival response to kaempferol. The role of autophagy was investigated by incubating HeLa cells with wortmannin and 3-MA that inhibit class III phosphatidylinositole-3-phosphate kinases, which are responsible for the early phases of autophagy, 32, 33 or with monensin, an ionophore impeding the late fusion between lysosomes and phagosomes. 34 Under these conditions, 24 h-treatment with 200 µM kaempferol resulted in a massive cell detachment from the flasks, which seemed to be much more evident in cells grown in lowglucose. Therefore, we stained the cells with propidium iodide and analyzed the occurrence of apoptosis by cytofluorometric analyses in both cell growth conditions. As expected, chemical inhibition of autophagy with wortmannin, 3MA or monensin completely abolished acridine orange positive cells (Suppl. Fig.  1 ) and concomitantly resulted in a massive induction of apoptosis ( Fig. 3A-C) , the extent of which was also related to the presence of glucose in culture media. We then transfected the cells with an siRNA against autophagy-related gene 5 homolog (siAtg5 cells), a protein involved in the early stages of autophagosome formation, 35 or with a scramble siRNA duplex (siScr). Figure 3D shows that, under these conditions, siAtg5 cells were committed to apoptosis with an extent of about 40%. These results confirmed that the activation of autophagy in response to kaempferol is a survival response.
In order to generalize the processes underlying kaempferol toxicity against carcinoma cell growth, we selected another carcinoma cell line, the gastric adenocarcinoma AGS. Results obtained with AGS mirrored those achieved in HeLa cells. In particular, a typical shrinkage of the cytoplasm and a significant increase of autophagic cells were evidenced upon treatment with 7 cells/ml in "measurement" buffer. Oxygen consumption of untreated (black draw) or kaempferol-treated cells (red draw) was then measured upon incubation with digitonin. 5 mM malate and glutamate (Mal/Glu), 5 mM succinate (Suc), 0.5 mM TMPD and 2 mM ascrbate (TMPD/Asc) were added as substrates of complex i, ii and iV, respectively. 100 nM rotenone (Rot), 1 µM antimycin A (AA) and 1 mM KcN were added to selectively inhibit complex i, iii and iV, respectively. Table on the right shows the values of oxygen consumption expressed as nmol of atomic oxygen/min/mg protein and represents the mean ± sD of n = 4 independent experiments. **p < 0.01. (c) 1 mg/ml of mouse liver mitochondria was incubated in experimental buffer supplemented of 1 mM NADh. Where indicated, 50 µM kaempferol (red draw), or 1 mM KcN (black draw) were added to mitochondrial suspension. DMsO (dotted green draw) was used as negative control. (D) heLa cells, cultured in hG or LG media were treated with 200 µM kaempferol. At indicated times, cells were harvested and used for ATP measurement. Data are expressed as percentage of control and represent the mean ± sD of n = 12 independent experiments. **p < 0.01.
shows that no significant change in ROS levels was evaluated during 12 h-treatment, whereas a sustained increase became evident between 18 and 24 h, time points consistent with the appearance of the early apoptotic markers. We then assessed whether ROS increase could be the event responsible for the activation of the pro-apoptotic members of MAPK family, JNK and p38
MAPK , that are known to be responsive to redox changes and reported to be activated by other polyphenols.
36 Figure 6B shows that phospho-active levels of p38 MAPK did not increase during treatment with kaempferol, whereas phospho-JNK immunoreactive PARP, which became evident at 36 h (Fig. 5C) . We then inhibited caspase activity by means of incubations with 20 µM of the pan-caspase inhibitor zVAD-fmk. Figure 5D shows that when caspase activity was inhibited (Suppl. Fig. 3) , the extent of apoptotic cells proportionally decreased, indicating that apoptosis was a caspase-dependent event. In the attempt to identify the switch between autophagy and apoptosis, we focused on the possible involvement of oxidative stress and the death pathways dependent on it. HeLa cells were treated with 200 µM kaempferol and analyzed cytofluorometrically for ROS production. of PARP (Suppl . Fig. 4 ). Next we pre-incubated the cells for 1 h with 10 mM sodium pyruvate to overcome glucose deprivationdependent impairment of glycolysis; then kaempferol was added and apoptosis measured cytofluorometrically. Figure 7B shows that pyruvate partially protected the cells from apoptosis after 36 h of treatment with 200 µM kaempferol. Nevertheless, such protection was lost at 48 h, confirming that refueling mitochondria with pyruvate is not sufficient to overcome kaempferol-mediated mitochondrial failure. Since Complex I was the main mitochondrial target of kaempferol, we further incubated the cells with 20 mM methyl succinate, a cell permeable substrate of Complex II and, then, added kaempferol. Figure 7C shows a significant protection of methyl succinate towards kaempferol-induced toxicity either at 36 or 48 h-treatment suggesting that fuel supplying to succinate dehydrogenase could revert cell demise. These results pointed out the existence of at least two distinct processes bands became significantly higher than control at 18 and 24 h, time points correlating with the appearance of ROS. On the basis of these results, we treated the cells with kaempferol, and only after 12 h we added the well-known thiol antioxidant NAC (5 mM), or the chemical inhibitor of JNK, SP600125 (10 µM), and evaluated the extent of apoptosis after 24 h. Figure 6C shows that both compounds significantly protected HeLa cells against kaempferol-mediated apoptosis, confirming the role of the redox activation of JNK in such an event.
Inhibition of glucose uptake and complex I is required for the induction of autophagy and sensitization to kaempferol. To connect kaempferol-mediated metabolic stress and autophagic response, we cultured HeLa cells in low-glucose medium and analyzed cell viability at longer time points (36 and 48 h). Figure  7A shows that cells were more susceptible to kaempferol-mediated apoptosis, a result also confirmed by western blot analyses Figure 8C shows that after 12 h of treatment with kaempferol, cells underwent apoptosis with percentages of SubG 1 population close to 40%. Moreover, cytofluorimetric analyses of HeLa cells upon staining with acridine orange indicated that AMPK inhibition completely abrogated autophagy (Fig. 8D) . Western blot of LC3 pointed out that AMPK-DN cells showed no significant increase of LC3 II immunoreactivity with respect to untreated cells, confirming that AMPK positively regulated autophagy upon treatment with kaempferol (Fig. 8E) . Evaluation of the phosphorylation state of AMPK in AGS cells also indicated that it was activated very early upon kaempferol exposure and that its inhibition resulted in a dramatic increase of apoptotic cells (Suppl. Fig. 2F and G) , thus strengthening the idea of a general mechanism of action for kaempferol in affecting carcinoma cell viability.
Under energetic stress, AMPK can activate autophagy by phosphorylating the mTOR-associated protein raptor, or the mTORupstream complex tuberous sclerosis complex 2 (TSC2). 14, 38 To define a possible link between AMPK and mTOR under our experimental conditions, we evaluated the expression levels of phospho-active mTOR. Figure 8F shows that phospho-mTOR concurring in kaempferol-induced toxicity: one occurring at early times due to decrease in glucose uptake, mainly responsible for autophagy induction; the other taking place later on, a consequence of mitochondrial OXPHOS impairment, mainly responsible for cell death.
Kaempferol-induced autophagy is mediated by AMPK/ mTOR pathway. In the attempt to elucidate the molecular factor(s) responsible for the induction of autophagy, we looked at AMPK. Indeed, AMPK has been previously suggested to activate autophagy under energetic stress, 37 in order to induce catabolic processes and deactivate ATP-consuming pathways. Cells were treated with 200 µM kaempferol and phospho-activated AMPK evaluated by western blot. Figure 8A shows that the phosphorylated levels of AMPK increased time dependently. We then supplemented cell media with the fuel supplies previously used, and analyzed the phospho-activation of AMPK by western blot. Figure 8B shows that pyruvate and succinate significantly lowered the expression levels of phospho-AMPK, whereas low-glucose conditions increased phospho-active levels of AMPK already without the addition of kaempferol, confirming that AMPK activation was an event dependent on the energetic state of the cell.
To assess the role of AMPK in kaempferol-mediated effects we transfected the cells with the dominant negative form of decreased time dependently upon treatment with 200 µM kaempferol. In particular, HeLa cells grown in low-glucose medium showed a marked decrease of phospho-mTOR immune-reactive band already after 6 h. In support to the idea that a crosstalk between AMPK and mTOR occurred in our conditions, western blot of AMPK-DN cells indicated that phospho-mTOR was not affected by kaempferol (Fig. 8E) .
Discussion
In this work we have dissected the antiproliferative effects of kaempferol, a member of the flavonoid subclass, in carcinoma cells. The results summarized in Figure 9 point out a multifaceted action of this compound that impinges mainly on cellular energetics. The data demonstrate that kaempferol impedes glucose uptake and that an inverse correlation between glucose availability and cell sensitivity to kaempferol occurs. Our results are in agreement with recently published data, in which the inhibition of glucose uptake is proposed to occur upon treatment with various polyphenols. 25, 26 It has been demonstrated that kaempferitrin, a diramnoside-derivative of kaempferol, directly binds to glucose transporter 4 and hinders glucose influx upon insulin stimulation. 2 However, the persistence of cell death upon pyruvate addition indicates that other pathways involved in energy production are compromised. Indeed, we found that kaempferol also induces a significant decrease of mitochondrial OXPHOS rate. Measurements of oxygen consumption pointed out that NADH-dependent respiration is inhibited by kaempferol, suggesting that it affects mitochondrial electron transfer chain at the level of Complex I. This result is further confirmed by data obtained with methyl succinate, which significantly prevents kaempferol-mediated apoptosis by supplying OXPHOS with reducible substrates at Complex II. On the basis of these results, and considering the strong similarity between the chemical structures of kaempferol and rotenone, it can be speculated that kaempferol could function by affecting electron flow at the level of the iron-sulfur cluster N2, however this aspect deserves to be deeply investigated.
The most intriguing aspect of our study is that carcinoma cells respond to kaempferol-induced bio-energetic impairment with the induction of autophagy that, in our experimental conditions, stands for a survival process. Indeed, both chemical inhibition of autophagy and siRNA against Atg5 result in an increased cell death. In the sequence of events underlying kaempferol toxicity, we demonstrate that autophagy is a reversible process that precedes the activation of cell death, because kaempferol withdrawal in the first 12 h of treatment results in the restoration of the cell capability to proliferate. Only a persistent inhibition of metabolic pathways (glycolysis and OXPHOS) can warrant the final elimination of cells via the mitochondrial apoptotic pathway. Interestingly, we found that the induction of apoptosis is a ROS-mediated and JNK-dependent event. This result corroborates many other observations that polyphenols, if added at pharmacological doses, can generate oxidative stress and induce apoptosis by the phospho-activation of MAPK family members. However, the evidence that NAC or the JNK inhibitor SP600125 results obtained in this work demonstrate that glucose consumption is affected and that the mTOR pathway inhibited upon treatment with kaempferol, thus confirming that our experimental conditions mirror those occurring upon energetic stress. In addition, artificial reduction of extracellular glucose robustly sensitizes HeLa cells to kaempferol, indicating that AMPK-elicited autophagy is mainly responsive to glucose deficiency. Conversely, the switch into apoptosis probably takes place when the mitochondrial function is compromised and the AMPK-mediated buffering response to glucose uptake inhibition is no longer sufficient to guarantee cell survival. This hypothesis is also strengthened to a great extent by apoptosis obtained upon the overexpression of the dominant negative form of AMPK, as well as by the results obtained upon incubation with pyruvate or succinate, which reinforces the assumption that a two-step process affecting cellular energetics occurs upon treatment with kaempferol.
Although our results show that kaempferol is an energetic stressor useful to inhibit proliferation of cancer cells, from a more general viewpoint, these data also provide important restrictions to the common opinion recently suggesting a promising use of polyphenols as anti-tumor compounds in virtue of their pro-oxidant properties. 23, 41 Indeed, since some members of polyphenols mimic kaempferol effects, they could be able to activate autophagy were able to revert apoptosis even when administered 12 h after kaempferol, points out that the induction of the apoptotic program is entirely subsequent to the activation of autophagy and, reasonably, occurs when autophagy is no longer able to counter kaempferol-mediated metabolic stress. In particular, the occurrence of the only caspase-9 cleavage at 24 h of treatment with the highest dose (200 µM) of kaempferol, indicates that this time point is slightly later the borderline in which autophagy (resistance) switches into apoptosis (surrender). This is in line with recent data from literature suggesting that autophagy is commonly triggered by tumor cells to survive starvation which is occurring during uncontrolled proliferation. 39 Among the proteins involved in survival response, we found that AMPK plays a pivotal role, being deeply involved in the induction of autophagy. It regulates catabolic and anabolic processes by sensing AMP concentration. 40 In order to maintain cellular energetic homeostasis, AMPK has been demonstrated to activate glucose uptake by enhancing transcription of the Rab GTPase Akt substrate of 160 kDa (AS160) and increase plasma membrane translocation of glucose transporter 4, as well as to increase glycolytic rate by inducing phospho-fructokinase 2 transcription. In response to metabolic stresses, it also has been suggested that AMPK activates autophagy by inhibiting mTOR pathway.
14 The of autophagy in the treatment of cancer progression, especially for those tumor histotypes able to activate autophagy as survival response. In addition, they highlight the great therapeutic potential of kaempferol in other human diseases, such as in the treatment of obesity. Indeed, as already suggested for other classes and enhance tumor resistance against conventional treatments, rather than rendering it more vulnerable to chemotherapies. This hypothesis is also strengthened by the knowledge of the scarce bio-availability of these molecules in vivo. 42, 43 Nevertheless, our data provide a rationale for combining kaempferol with inhibitors LG media were treated with 200 µM kaempferol. At the indicated times, cells were lysed and 30 µg of total cell extracts were loaded for the immunodetection of the basal and phosphorylated form of mTOR. Actin was used as loading control. immunoblots are from one experiment representative of three that gave similar results.
investigations are necessary to comprehend the real efficacy of kaempferol in vivo and to assess therapeutic approaches based on the consumption of kaempferol-containing foods or the purified molecule.
Materials and Methods
Materials. Acridine orange (318337), compound C (P5499), dimethyl sulfoxide (DMSO, 154938), kaempferol (K0133), of polyphenols, kaempferol might reduce glucose uptake in the intestine and function as hypo-caloric food supplement. 44, 45 Kaempferol could be also useful in the treatment/prevention of neurodegenerative diseases, where self-digestion of the cells has been indicated to represent a protective process able to increase turnover of proteins and organelles. [46] [47] [48] Preliminary results from our laboratory indicate that low doses of kaempferol are still able to induce autophagy, without affecting viability of different cell lines, such as those of neuronal origin. However, additional Figure 9 . Model of kaempferol-induced antiproliferative effects. Kaempferol affects cellular energetics by two distinct mechanisms which occur sequentially: the earlier involves a restriction of glucose uptake and glycolysis efficiency; the latter concerns the decrease of mitochondrial respiration and ATP production. Adenocarcinoma cell lines heLa and AGs undergo autophagy as survival response, which is reasonably maintained by increasing protein and organelle turnover, a strategy necessary for keeping tumor survival even under energetic stress. Kaempferol removal can restore normal cell growth and viability as long as it occurs within 12 h of treatment. conversely, the exacerbation of the energetic stress results in ROs production and JNK activation, which ultimately leads the cells to activate apoptosis via the mitochondrial pathway.
p38
MAPK (Thr180/Tyr182) (9216), anti-phospho-JNK (9255) were from Cell Signaling Technology; anti-caspase-8 (sc-70503) anti-PARP (sc-53643), anti-caspase-3 (sc-56053) anti-GAPDH (sc-47724), anti AMPK-α1/2 (sc-74461) were from Santa Cruz.
Cell transfections. Cells were transfected by electroporation using a Gene Pulser Xcell system (Bio-Rad). 24 h after plating, 50% confluent HeLa cells were electroporated with an LC3-EGFP-containing plasmid, 52 kindly provided by Prof. Francesco Cecconi, Department of Biology, University of Rome "Tor Vergata," with a pcDNA3 empty vector or with a pcDNA3 vector containing the myc-tagged coding sequence for the α2 subunit of AMPK carrying the T→A substitution at the residue 172 (kindly provided by Prof. David Carling from the Clinical Sciences Centre, Imperial College, Hammersmith Hospital, Du Cane Road, London, UK). After transfection, cells were immediately seeded into fresh medium and used after 48 h, since this time was sufficient to significantly increase the expression of this dominant/negative form of AMPK. 53 Knockdown of Atg5 expression was performed by transfecting the cells with On-TargetPlus SmartPool small interference RNA (siRNA) (Darmacon, Lafayette, CO). Controls were transfected with a scramble siRNA duplex, which does not present homology with any other human mRNAs (siScr).
Fluorescence microscopy analyses. Cells expressing EGFP-LC3 were stained with 75 nM Lysotracker Red, fixed with 4% paraformaldehyde and rapidly visualized by fluorescence microscopy. Images of cells were digitized with a Delta Vision Restoration Microscopy System (Applied Precision Inc., Issaquah, WA) equipped with an Olympus IX70 fluorescence microscope.
Oxygen consumption. Oxygen consumption of intact cells was measured by a Clark-type oxygen electrode (Gilson Medical Electronic, 3000W mod 5/6H) maintained at 37°C. Oxygen consumption by each complex was determined according to Villani and Attardi. 54 Mitochondrial oxygen consumption on intact mitochondria from mouse liver was performed as previously described. 53 Before each analysis, state IV/state III ratio was measured by adding ADP to check the integrity of mitochondrial fractions. Extracellular lactate assay. 10 µl of trichloroacetic acid-precipitated proteins from cell media was incubated at room temperature in 290 µl of a 0.2 M glycine/hydrazine buffer, pH 9.2, containing 0.6 mg/ml NAD + and 17 U/ml lactate dehydrogenase. NAD + reduction was followed at 340 nm and nmoles of NADH formed were considered stoichiometrically equivalent to extracellular lactate.
Measurement of 2-NBDG uptake. Cells were incubated with 100 µM 2-NBDG, a fluorescent derivative of 2-deoxy-Dglucose, washed with PBS and analyzed cytofluorometrically. Alternatively, cells plated on coverslips were incubated for 30 min with 100 µM 2-NBDG and visualized by fluorescence microscopy.
ATP evaluation. ATP levels were measured by the ATP Bioluminescence Assay Kit CLS II (Roche Applied Science).
ROS evaluation. Before treatments, cells were pre-incubated with 50 µM DHDCF-DA for 12 h at 37°C. After treatments, cells were washed and resuspended in ice-cold PBS. The fluorescence intensities of DCF, formed by the reaction of DCF-DA 3-methyladenine (3-MA, M9281), monensin (M5273), N-acetylcysteine (A9165), propidium iodide (P4170), methyl succinate (M81101), sodium pyruvate (S8636) and donkey antigoat (G7767) were from Sigma. 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose (2-NBDG, N13195) and Lysotracker Red ® (L7528) were from Invitrogen (San Giuliano Milanese, Italy); zVAD-fmk (ALX-350-020-M001) and wortmannin (ALX-260-039-M001) were from Alexis Biochemicals; JNK Inhibitor SP600125 (420119) and 2',7'-dihydrodichlorofluorescin diacetate (287810) were from Calbiochem. Goat anti-mouse (172-1011) and anti-rabbit (172-1019) and IgG (H + L)-horseradish peroxidase conjugated were from Bio-Rad (Hercules, CA); anti IgG2a (sc-2061) was from Santa Cruz Biotechnology. All other chemicals were obtained from Merck.
Cell cultures. Human epithelial and gastric carcinoma cells HeLa and AGS were purchased from the European Collection of Cell Culture, and grown at 37°C in an atmosphere of 5% CO 2 . HeLa cells were cultured in DMEM containing 25 mM glucose (BE12-604F) or 5.6 mM glucose (low glucose, BE12-707F), whereas AGS were grown in F12-HAM'S (BW12-615F). All media were from Lonza and were supplemented with 10% fetal bovine serum (BE14-801F), 2 mM L-glutamine (BE17-605E), 1,000 U/ml penicillin-streptomycin (Lonza, DE17-602E).
Treatments. A 20 mM kaempferol solution was prepared by dissolving the lyophilized compounds in DMSO. Treatments were done with different amounts of kaempferol in medium supplemented with serum. As a control, equal volumes of DMSO (1%) were added to untreated cells. The pan-caspase inhibitor, zVAD-fmk was used at the final concentration of 20 µM. The autophagy inhibitors 3-MA, wortmannin and monensin were pre-incubated for 1 h before the addition of kaempferol and used at the final concentration of 10 mM, 1 µM and 2.5 µM, respectively. Sodium pyruvate and methyl succinate were pre-incubated for 1 h and used at the final concentrations of 10 and 20 mM, respectively. The AMPK inhibitor, Compound C was used on AGS at the final concentration of 5 µM, added 1 h before treatment with kaempferol and maintained throughout the experimental time.
Analysis of cell viability, apoptosis and autophagy. The percentages of apoptotic cells were evaluated upon staining with propidium iodide as previously described. 49 Alternatively, Trypan blue-positive cells were counted by optic microscopy. For autophagy determination, cells were incubated with 500 nM acridine orange. The increase of FL-3 emitting cells (bright red) is considered proportional to the increase of intracellular acidification, which, in turn, mostly relies upon the accumulation of autolysosomes. 31, 50 Western blot analyses. Total protein lysates were obtained as previously reported, 51 electrophoresed by SDS-PAGE and blotted onto PVDF membrane (Bio-Rad). Primary antibodies used are as follow: polyclonal anti-caspase-9 (9502), anti-phospho-Thr 172 AMPK (2535), anti-phospho-Ser 2448 -mTOR (2974), anti-mTOR (2983), anti-Atg5 (2630) were from Cell Signaling Technology; anti-JNK (sc-474), anti-p38 MAPK (sc-7149), antiactin (sc-1615) were from Santa Cruz Biotechnology. Monoclonal anti-LC3 (0260LC3-3-2G6) was from Nanotools; anti-phospho-
